Aktienanalyse zu Akanda Corp (AKAN)AKANAkanda Corp

Akanda Corp is a United Kingdom-based company. The Company, through its subsidiaries, operates as a cannabis cultivation, manufacturing, and distribution company. It is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary, First Towers, which is based in Mexico. It operates through four segments, which include Infrastructure, Cultivation, Distribution and Corporate. The Infrastructure segment offers leasing or rental of fiber optic networks and telecommunication towers at First Towers in Mexico. The Cultivation segment is focused on the cultivation of medical cannabis and medical cannabis biomass. The Distribution segment is engaged in the sale and distribution of medical cannabis products. The Corporate segment undertakes management and treasury services. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

Given the current price of 0.84, an RSI of 17.284 indicating oversold conditions, and a staggering 92.42% year-to-date decline, AKAN is not a good buy right now. The company has severe financial struggles, with a gross margin of -33.28% in Q2 2026 and a net income loss of -6196557.00 USD. The main risk is its ongoing financial instability, as evidenced by a current ratio of 0.22, indicating potential liquidity issues.